Nifty Pharma

Torrent Pharmaceuticals and Mankind Pharma were the top gainers on the Nifty Pharma index with more than 3% rally each. Cipla, Divi’s Laboratories, Laurus Labs, Alkem Laboratories and Sai Life Sciences shares rose over 2% each.

The Nifty Pharma index rose 1.4% on 8 June, defying the broader market selloff, supported by heavyweight stocks like JB Chemicals and Alkem Laboratories. Despite some losses in others, analysts suggest pharma stocks are resilient during market instability due to consistent healthcare demand.

The Nifty Pharma index has surged nearly 11% over the past month, significantly outperforming the Nifty 50, which declined 3.6% during the same period. On a year-to-date (YTD) basis, the Nifty Pharma index has gained 9.4%, while the benchmark Nifty 50 has fallen by an equal margin.

Stock Market Today: The Nifty Pharma index gained 1.9% during the intraday trades on Wednesday. Alkem and Zydus stood among key gainers:Should you buy or sell pharma stocks amid a releif rally?

Stock Market Today: Nifty Pharma Index gained more than 1% amid weak Indian stock market: Cipla and Laurus Labs among key gainers

Pharma stocks showed resilience on July 9, with several companies like Laurus Labs and Lupin rising up to 3%. US President Donald Trump has reiterated that he would impose very high tariffs on pharmaceutical imports to the US.

India's pharmaceutical sector faced a 6% decline in the Nifty Pharma index in 2025, while the Nifty 50 index rose 8%. Major firms experienced significant losses, though some companies like Laurus Labs and Abbott India saw gains amid investor concerns over tariffs and macroeconomic issues.

Indian pharmaceutical stocks fell sharply on June 17 after President Trump announced imminent tariffs on pharmaceutical imports. The Nifty Pharma index dropped over 2 percent, signaling significant investor concern about revenue disruption for Indian drugmakers reliant on the US market.

Key pharma stocks, including Granules India and Gland Pharma, have shown substantial recovery, with the Nifty Pharma index increasing 13%. This rebound is attributed to improved global trade sentiment and US policy changes favoring generic drug manufacturers.

Stock Market today: Nifty Pharma index cracked more than 2% in the morning trade on Monday as Trump proposes to cut drug prices in the US by 30-80%. Sun Pharma's share price led the fall, declining more than 5%.